Drug Shortage Report for TEVA-CLOBAZAM

Last updated on 2025-02-21 History
Report ID 229230
Drug Identification Number 02238334
Brand name TEVA-CLOBAZAM
Common or Proper name CLOBAZAM 10MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CLOBAZAM
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes PP 30
ATC code N05BA
ATC description ANXIOLYTICS
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2024-05-29
Estimated end date 2025-04-20
Actual end date 2025-02-20
Shortage status Resolved
Updated date 2025-02-21
Company comments Supply issues with API Supplier in Europe.
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2025-02-21 English Compare
v17 2025-02-20 French Compare
v16 2025-02-20 English Compare
v15 2024-12-16 French Compare
v14 2024-12-16 English Compare
v13 2024-12-16 English Compare
v12 2024-11-01 French Compare
v11 2024-11-01 English Compare
v10 2024-09-19 French Compare
v9 2024-09-19 English Compare
v8 2024-09-19 French Compare
v7 2024-09-19 English Compare
v6 2024-07-04 French Compare
v5 2024-07-04 English Compare
v4 2024-06-13 French Compare
v3 2024-06-13 English Compare
v2 2024-05-30 French Compare
v1 2024-05-30 English Compare

Showing 1 to 18 of 18